Target intelligence / Profile preview

Thyroid hormones (TH)

Target
TH
Molecular classification
Hormone, Other
01

Overview

Thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3), are essential regulators of metabolism that undergo significant enterohepatic circulation. After being processed by the liver and excreted into the bile, these hormones enter the intestinal lumen, where they can be reabsorbed into the bloodstream (StatPearls, 2023). This physiological process becomes a therapeutic target in conditions of hormone excess, such as thyroid storm or refractory hyperthyroidism, where binding agents like cholestyramine are employed to trap the hormones in the gut and promote their elimination via feces (PubMed, PMID: 3904281). Conversely, the presence of certain minerals, fibers, or medications in the lumen can inadvertently bind thyroid hormones, leading to reduced bioavailability of oral thyroid replacement therapy in hypothyroid patients (NIH, 2022). Understanding the dynamics of thyroid hormones within the gut is crucial for optimizing treatment efficacy and avoiding drug-drug interactions. Clinicians must often adjust the timing of thyroid medication relative to other luminal binders to maintain euthyroidism. The sequestration of these hormones in the gut provides a rapid, non-systemic method to reduce toxic levels during acute thyrotoxic crises.

Other names
Triiodothyronine (T3)Thyroxine (T4)L-thyroxineLiothyronineEnterohepatic thyroid hormones
02

Mechanism of action

Bile acid sequestrants and other resins bind thyroid hormones in the intestinal lumen through ion-exchange or physical adsorption, preventing their reabsorption and increasing fecal excretion.

03

Biological functions

Metabolism regulationEnterohepatic circulationGrowth and developmentThermoregulation
04

Disease associations

HyperthyroidismThyroid stormThyrotoxicosisHypothyroidism
05

Safety considerations

Iatrogenic hypothyroidismReduced absorption of concomitant medicationsFat-soluble vitamin deficiencyGastrointestinal distress
06

Interacting drugs

Cholestyramine

8 more in the full profile.

07

Biomarkers

Serum Free Thyroxine (FT4)Serum Free Triiodothyronine (FT3)Thyroid Stimulating Hormone (TSH)

Beyond the preview

Go deeper on Thyroid hormones (TH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid hormones (TH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call